SCHEDULE 13D

CUSIP No.

02081G102

Name of reporting person

L-5 Healthcare Partners, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 9,214,698.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 9,214,698.00

Aggregate amount beneficially owned by each reporting person

9,214,698.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

6.45 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

Percentage of class in row (13) represented by amount in row (11) is based on a denominator consisting of 141,815,115 shares of Common Stock outstanding as reported in the Issuer's Form S-3ASR filed on November 15, 2024, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer.

SCHEDULE 13D

CUSIP No.

02081G102

Name of reporting person

Paul Segal

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 9,214,698.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 9,214,698.00

Aggregate amount beneficially owned by each reporting person

9,214,698.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

6.45 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

Amounts shown in row 8 and row 10 represent 9,214,698 shares of Common Stock held by L-5 Healthcare Partners, LLC. Percentage of class in row (13) represented by amount in row (11) is based on a denominator consisting of 141,815,115 shares of Common Stock outstanding as reported in the Issuer's Form S-3ASR filed on November 15, 2024, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer.

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock, par value $0.0001 per share

(b)

Name of Issuer:

Alphatec Holdings, Inc.

(c)

Address of Issuer's Principal Executive Offices:

1950 Camino Vida Roble, Carlsbad, CALIFORNIA , 92008.

Item 5.

Interest in Securities of the Issuer

(a)

Item 5 of this Schedule 13D is hereby amended and restated in its entirety as follows: The information contained on the cover pages to this Schedule 13D is incorporated herein by reference. The aggregate percentage of Common Stock reported owned by each person named herein is based upon 141,815,115 shares of Common Stock outstanding as of November 13, 2024, which is the total number of shares of Common Stock outstanding as reported in the Issuer's Form S-3ASR filed with the Securities and Exchange Commission on November 15, 2024, together with 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer. L-5 directly holds 9,214,698 shares of Common Stock (which includes 8,081,538 shares of Common Stock and 1,133,160 shares of Common Stock issuable upon the exercise of a warrant of the Issuer) reported in this Schedule 13D. As a result of his relationship with L-5, Paul Segal may be deemed the beneficial owner of all such shares of Common Stock. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

(b)

The information set forth in Item (5)(a) of this Schedule 13D is incorporated by reference in its entirety into this Item 5(b).

(c)

The transactions effected by the Reporting Persons during the past 60 days are set forth on Schedule 1 attached hereto.

(d)

Not applicable.

(e)

Not Applicable.

Item 7.

Material to be Filed as Exhibits.

Schedule of Transactions for Item 5(c) of Amendment No. 8.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

L-5 Healthcare Partners, LLC

Signature:	/s/ Paul Segal
Name/Title:	Paul Segal, President
Date:	02/06/2025

Paul Segal

Signature:	/s/ Paul Segal
Name/Title:	Paul Segal
Date:	02/06/2025